X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Aventis Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aventis Pharma Quarterly Results   (HOCM)

Here are the latest quarterly results of Aventis Pharma. For more details, see the Aventis Pharma financial fact sheet and Aventis Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Aventis Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
3
Mar-17
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
3
Sep-18
8-Qtr Chart
Click to enlarge
Net Sales Rs m6,2425,5296,0066,6756,7046,1776,8367,438 
Other income Rs m148159284208182226208262 
Turnover Rs m6,3905,6886,2906,8836,8866,4037,0447,700 
Expenses Rs m4,7954,5144,8524,8385,3604,8335,1915,565 
Gross profit Rs m1,4471,0151,1541,8371,3441,3441,6451,873 
Depreciation Rs m300253255257257254254260 
Interest Rs m340011000 
Profit before tax Rs m1,2929171,1831,7881,2581,3161,5991,875 
Tax Rs m486317446625498491603683 
Profit after tax Rs m8066007371,1637608259961,192 
Gross profit margin %23.218.419.227.520.021.824.125.2 
Effective tax rate %37.634.637.735.039.637.337.736.4 
Net profit margin %12.910.912.317.411.313.414.616.0 
Diluted EPS Rs 35.0 26.1 32.0 50.5 33.0 35.8 43.2 51.8  
Diluted EPS (TTM) Rs 129.8 133.1 130.1 143.6 141.6 151.3 162.6 163.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Aventis Pharma 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   PANACEA BIOTECH  MERCK LTD  FRESENIUS KABI ONCO.  STRIDES PHARMA SCIENCE  LUPIN LTD  

Compare SANOFI INDIA With:   PANACEA BIOTECH  MERCK LTD  FRESENIUS KABI ONCO.  STRIDES PHARMA SCIENCE  LUPIN LTD  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Will Low Inflation Encourage RBI to Cut Rates?(Podcast)

In a week full of macroeconomic developments, anxiety over third quarter results and trade war concerns, we take a look at the key topics that swayed the markets this week.

Views on news

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Our First Bluechip Stock Recommendation in Smart Money Secrets(The 5 Minute Wrapup)

Jan 9, 2019

For the first time, we have recommended a bluechip stock in Smart Money Secrets.

3 Stocks in Super Investor Sumeet Nagar's Portfolio That You Can Buy Right Now(The 5 Minute Wrapup)

Jan 11, 2019

The reasons that make these six stocks in Sumeet Nagar's portfolio so compelling

The Biggest Trend That I'm Seeing in the Market Today(The 5 Minute Wrapup)

Jan 10, 2019

For the first time ever, a majority of Indian households, will start to benefit from stock market wealth.

My First Stock Trading Recommendation For 2019(Profit Hunter)

Jan 10, 2019

My first trading recommendation for 2019 is a bluechip auto stock. Find out everything about it right away.

A Proven Super Investor Can Lead to Great Wealth(Profit Hunter)

Jan 7, 2019

Following a super investor can certainly help build a portfolio that can create significant wealth in the long term.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jan 18, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANOFI INDIA

SANOFI INDIA - MYLAN COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS